These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5997225)

  • 1. [Changes in the Color Pyramid Test induced by amphetamine shock in a group of schizophrenics].
    Merini A; D'Urso L
    Riv Sper Freniatr Med Leg Alien Ment; 1966 Oct; 90(5):1211-23. PubMed ID: 5997225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical characteristics of chronic schizophrenic patients presenting with severe anhedonia].
    Loas G; Noisette C; Legrand A; Boyer P; Delahousse J
    Encephale; 1996; 22(5):351-8. PubMed ID: 9035991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Color analysis of the pyramid test.
    O'REILLY PO; BLEWETT D
    Dis Nerv Syst; 1959 May; 20(5, Part 1):211-3. PubMed ID: 13652809
    [No Abstract]   [Full Text] [Related]  

  • 4. [The colored pyramid test in schizophrenics].
    CATAPANO VD
    Rass Studi Psichiatr; 1960; 49():729-54. PubMed ID: 13691539
    [No Abstract]   [Full Text] [Related]  

  • 5. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
    Weiner I; Bernasconi E; Broersen LM; Feldon J
    Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The development of an experimental psychological test for the diagnosis of control anxiety in paranoid schizophrenics].
    Sorgatz H; Eckardt M
    Z Exp Angew Psychol; 1980; 27(2):277-94. PubMed ID: 7395275
    [No Abstract]   [Full Text] [Related]  

  • 7. [Psychotherapeutic and psychological achievement test experiences in a schizophrenic group].
    Grünberger J; Salvendy JT
    Z Psychother Med Psychol; 1968 Mar; 18(2):58-66. PubMed ID: 4876707
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rorschach response process in schizophrenia].
    Harada N
    Seishin Shinkeigaku Zasshi; 1996; 98(6):378-412. PubMed ID: 8810861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychological dysfunction in schizophrenia and affective disease.
    Taylor MA; Redfield J; Abrams R
    Biol Psychiatry; 1981 May; 16(5):467-78. PubMed ID: 7272376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of outcome in schizophrenia. (The long-term prognostic test index).
    Piotrowski ZA; Efron HY
    Proc Annu Meet Am Psychopathol Assoc; 1966; 54():312-34. PubMed ID: 5951923
    [No Abstract]   [Full Text] [Related]  

  • 12. Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia.
    Addington J; Addington D
    J Psychiatry Neurosci; 1993 Jan; 18(1):18-23. PubMed ID: 8461276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodialysis for uremic schizophrenics: no psychiatric improvement.
    Hariprasad MK; Nadler IM; Eisinger RP
    J Clin Psychiatry; 1981 May; 42(5):215-6. PubMed ID: 7217028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anhedonia in schizophrenia].
    Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
    Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Schizophrenia and violence, incidence and risk factors: a Tunisian sample].
    Ellouze F; Ayedi S; Masmoudi S; Bakri L; Chérif W; Zramdini R; Largueche M; Amri H; Ben Abla T; M'rad MF
    Encephale; 2009 Sep; 35(4):347-52. PubMed ID: 19748371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploratory eye movement dysfunctions in patients with schizophrenia: possibility as a discriminator for schizophrenia.
    Matsushima E; Kojima T; Ohta K; Obayashi S; Nakajima K; Kakuma T; Ando H; Ando K; Toru M
    J Psychiatr Res; 1998; 32(5):289-95. PubMed ID: 9789207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How serious is schizophrenia? Comments on prognosis.
    Harding CM; Strauss JS
    Biol Psychiatry; 1984 Dec; 19(12):1597-600. PubMed ID: 6518210
    [No Abstract]   [Full Text] [Related]  

  • 19. Schizophrenics' judgments of schizophrenic test responses.
    Hunt WA; Walker RE
    J Clin Psychol; 1966 Jan; 22(1):118-20. PubMed ID: 5970252
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ego-psychopathology of the schizophrenic syndrome. Empirical evidence for a phenomenological model (author's transl)].
    Scharfetter C; Brauchli B; Weber A
    Nervenarzt; 1982 May; 53(5):262-7. PubMed ID: 7099311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.